| |||
 | |||
 |
Hawthorn | ||
| |||
| |||
| |||
|
Creatine | ||
|
Tyrosine | ||
| |||
| ||||
| Pronunciation |
 (klor
fen IR a meen, fen il EF rin,
fen il proe pa NOLE a meen, & bel a DON a AL ka
loydz) |
 |
| U.S. Brand Names |
| Atrohist® Plus; Phenahist-TR®; Phenchlor® S.H.A.; Ru-Tuss®; Stahist® |
|
| Generic Available |
|
Yes |
|
| Synonyms |
| Phenylephrine, Chlorpheniramine, Phenylpropanolamine, and Belladonna Alkaloids; Phenylpropanolamine, Chlorpheniramine, Phenylephrine, and Belladonna Alkaloids |
|
| Pharmacological Index |
|
Cold Preparation |
|
| Use |
|
Relief of symptoms resulting from irritation of sinus, nasal, and upper respiratory tract tissues, including nasal congestion, watering eyes, and postnasal drip; this product contains anticholinergic agents and should be reserved for patients who do not respond to other antihistamine/decongestants |
|
| Pregnancy Risk Factor |
|
C |
|
| Usual Dosage |
|
Children greater than or equal to 12 years and Adults: Oral: 1 tablet morning and evening, swallowed whole |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
Use with caution since phenylpropanolamine & phenylephrine are sympathomimetic amines which could interact with epinephrine to cause a pressor response |
|
| Dental Health: Effects on Dental Treatment |
|
Chlorpheniramine: Prolonged use will cause significant xerostomia Phenylephrine, Phenylpropanolamine: Up to 10% of patients could experience tachycardia, palpitations, and dry mouth; use vasoconstrictor with caution |
|
| Dosage Forms |
|
Tablet, sustained release: Chlorpheniramine 8 mg, phenylephrine 25 mg, phenylpropanolamine 50 mg, hyoscyamine 0.19 mg, atropine 0.04 mg, and scopolamine 0.01 mg |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
